Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Allerg Immunol (Paris) ; 33(10): 399-403, 2001 Dec.
Article in French | MEDLINE | ID: mdl-11802481

ABSTRACT

Drugs administrated to pregnant women must be carefully monitored. Prevention of dietary sensitization in foetus via the mother is still discussed. However, it must not induce any dietary deficiency to both the mother and the foetus. Environmental prevention is also controversial. Asthmatic pregnant women must be treated because under- or non treatment is more dangerous for both the woman and the foetus compared to eventual drug side effect. Asthma must be treated with inhaled glucocorticosteroid in order to be stabilized because giving birth is the only moment which can not be interrupted. Antihistamine-H1 which can be used during pregnancy are dexchlorpheniramine for the first and second third and cetirizine during the last third of the pregnancy.


Subject(s)
Abnormalities, Drug-Induced/prevention & control , Anti-Allergic Agents/therapeutic use , Pregnancy Complications/immunology , Abnormalities, Drug-Induced/etiology , Adrenal Cortex Hormones/adverse effects , Adrenal Cortex Hormones/therapeutic use , Adult , Anti-Allergic Agents/adverse effects , Anti-Asthmatic Agents/adverse effects , Anti-Asthmatic Agents/therapeutic use , Asthma/drug therapy , Bronchodilator Agents/adverse effects , Bronchodilator Agents/therapeutic use , Contraindications , Environmental Exposure , Female , Fetus/drug effects , Food Hypersensitivity/diet therapy , Histamine H1 Antagonists/adverse effects , Histamine H1 Antagonists/therapeutic use , Humans , Hypersensitivity, Immediate/prevention & control , Infant, Newborn , Maternal-Fetal Exchange , Nutrition Disorders/etiology , Pregnancy , Pregnancy Complications/drug therapy , Puerperal Disorders/prevention & control
SELECTION OF CITATIONS
SEARCH DETAIL
...